Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug

Summary

The purpose of this study is to define the absorption, breakdown and excretion of a single dose of radiolabelled SB-649868 and its breakdown products by measuring their concentration in blood, urine and faeces over a 7-10 day period. "Radiolabelled" means that the test drug has a radioactive component to help us track the drug. The safety and tolerability of the test drug will also be assessed.

Timeline

Start

2007-06-08

Primary completion

2007-08-10

Completion

2007-08-10

Drugs

Indications